JP2006520184A5 - - Google Patents

Download PDF

Info

Publication number
JP2006520184A5
JP2006520184A5 JP2004547452A JP2004547452A JP2006520184A5 JP 2006520184 A5 JP2006520184 A5 JP 2006520184A5 JP 2004547452 A JP2004547452 A JP 2004547452A JP 2004547452 A JP2004547452 A JP 2004547452A JP 2006520184 A5 JP2006520184 A5 JP 2006520184A5
Authority
JP
Japan
Prior art keywords
protein variant
naturally occurring
protein
allergen
variant according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004547452A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006520184A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2003/000744 external-priority patent/WO2004039834A2/en
Publication of JP2006520184A publication Critical patent/JP2006520184A/ja
Publication of JP2006520184A5 publication Critical patent/JP2006520184A5/ja
Pending legal-status Critical Current

Links

JP2004547452A 2002-11-01 2003-10-31 組換えタンパク質変種 Pending JP2006520184A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42298302P 2002-11-01 2002-11-01
DKPA200201686 2002-11-01
PCT/DK2003/000744 WO2004039834A2 (en) 2002-11-01 2003-10-31 Recombinant protein variants

Publications (2)

Publication Number Publication Date
JP2006520184A JP2006520184A (ja) 2006-09-07
JP2006520184A5 true JP2006520184A5 (https=) 2006-11-09

Family

ID=35719237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004547452A Pending JP2006520184A (ja) 2002-11-01 2003-10-31 組換えタンパク質変種

Country Status (8)

Country Link
US (2) US7384635B2 (https=)
EP (1) EP2270164A3 (https=)
JP (1) JP2006520184A (https=)
CN (1) CN1714153A (https=)
AU (1) AU2003275941A1 (https=)
CA (1) CA2503886A1 (https=)
PL (1) PL375218A1 (https=)
WO (1) WO2004039834A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002070665A2 (en) * 2001-03-02 2002-09-12 The Rockefeller University Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
AT501101B1 (de) * 2004-12-02 2008-01-15 Biomay Ag Protein-allergen-derivat
ZA200707413B (en) 2005-03-18 2009-01-28 Cytos Biotechnology Ag Cat allergen fusion proteins and uses thereof
HUE029021T2 (en) 2005-06-21 2017-02-28 Xoma (Us) Llc IL-1beta-binding antibodies and fragments thereof
WO2008010837A2 (en) * 2005-12-15 2008-01-24 The Regents Of The University Of California Noncompetitive immunoassays to detect small molecules
EP3124045A3 (en) 2006-12-20 2017-05-03 Xoma (Us) Llc Treatment of il-1 beta related diseases
EP2028188A1 (en) * 2007-08-21 2009-02-25 Biomay AG Hypoallergenic molecules
SI2391650T1 (sl) 2007-12-20 2015-03-31 Xoma (Us) Llc Postopki za zdravljenje protina
ITMI20111489A1 (it) * 2011-08-03 2013-02-04 Lofarma Spa Varianti ipoallergeniche dell'allergene maggiore mal d 1 di malus domestica
WO2013096516A1 (en) 2011-12-19 2013-06-27 Xoma Technology Ltd. Methods for treating acne
RU2597782C1 (ru) * 2015-08-25 2016-09-20 Василий Николаевич Яковлев Способ определения содержания продуктов протеолиза в плазме крови и диагностическая тест-система для его осуществления
WO2021097174A1 (en) * 2019-11-13 2021-05-20 The Regents Of The University Of Michigan Nanoemulsion compositions for treating aeroallergen associated allergy and inflammation
WO2021178572A1 (en) * 2020-03-03 2021-09-10 The Regents Of The University Of California Non-invasive detection of salivary autoantibodies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT401180B (de) * 1990-08-13 1996-07-25 Biomay Biotech Prod Für das baumpollenallergen p14 codierende rekombinante dna-moleküle, daraus hergestellte und abgeleitete polypeptide und deren verwendung
JP3316535B2 (ja) * 1995-03-28 2002-08-19 アサヒビール株式会社 ダニアレルゲンの改変体およびその製造法
DE19810906A1 (de) 1998-03-13 1999-09-16 Basf Ag Reaktivfarbstoffe mit einem Kombinationsanker
PL194804B1 (pl) * 1998-03-16 2007-07-31 Alk Abello As Zrekombinowany alergen, sposób przygotowywania zrekombinowanego alergenu, kompozycja farmaceutyczna oraz zastosowanie zrekombinowanego alergenu do przygotowywania leku do wywoływania odpowiedzi immunologicznej u osobnika i do przygotowywania leku do leczenia, zapobiegania lub osłabiania reakcji alergicznych
ATE414773T1 (de) 2000-11-16 2008-12-15 Alk Abello As Mutante allergene
WO2002070665A2 (en) * 2001-03-02 2002-09-12 The Rockefeller University Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
US7290199B2 (en) * 2004-11-19 2007-10-30 International Business Machines Corporation Method and system for improved buffer utilization for disk array parity updates

Similar Documents

Publication Publication Date Title
JP2006520184A5 (https=)
JP2010516290A5 (https=)
JP6300907B2 (ja) イエダニアレルギーの処置のための連続したオーバーラップペプチド
JP2015521467A5 (https=)
US20110150920A1 (en) Allergy Vaccines Containing Hybrid Polypeptides
WO2013113076A1 (en) Modified epitopes for boosting cd4+ t-cell responses
JP2024028887A (ja) 偽ウイルス粒子及びその使用
JP2021510169A (ja) アトピー性皮膚炎の治療及び/または予防のためのil−31のペプチド免疫原ならびにその製剤
CN103596971B (zh) 通过删除由nkt细胞识别的表位来调整抗原免疫原性
US20220088167A1 (en) Vaccine composition for preventing tuberculosis, comprising glycosylated ag85a protein and method for preparing same
JP2006520184A (ja) 組換えタンパク質変種
CN1414972A (zh) 通过消除t-细胞表位来降低异源蛋白的免疫原性的方法
CN103874509B (zh) 来自苹果的主要变应原Mal d 1的低变应原性变体
JP2016104796A (ja) アレルギー治療に用いるカベイラクサ(Parietariajudaica)の脂質輸送タンパク質ファミリーに属する低アレルギー誘導性のキメラタンパク質
AU2004240831B2 (en) Hypoallergenic variants of the Parietaria judaica major allergens, uses thereof and compostions comprising them
US20180002387A1 (en) Variants of group 5 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues
CA2558660C (en) Fusion proteins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same
WO2023130096A2 (en) Coronavirus vaccine compositions and uses thereof
EP2607376A1 (en) Hypoallergenic allergen derivatives of Pru p 3 for immunotherapy of IgE-mediated peach allergy
TWI276636B (en) Modified mite allergen and pharmaceutical uses thereof
ES2384231T3 (es) Proteínas híbridas de pincipales alérgenos de Parietaria judaica y usos de las mismas
Cromwell Engineering allergy vaccines: approaches towards engineered allergy vaccines
CN107353339A (zh) Gas7肿瘤抗原及其应用